Campbell & CO Investment Adviser LLC Chimerix Inc Transaction History

Campbell & CO Investment Adviser LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.34 - $5.34 $71,556 - $285,156	-53,400 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$4.58 - $6.8 $25,648 - $38,080	5,600 Added 11.72%	53,400 $245,000
Q4 2021 Feb 10, 2022	BUY	$5.23 - $7.18 $180,958 - $248,428	34,600 Added 262.12%	47,800 $307,000
Q3 2021 Nov 10, 2021	BUY	$5.94 - $8.75 $78,408 - $115,500	13,200 New	13,200 $82,000
Q4 2018 Feb 08, 2019	SELL	$2.24 - $3.9 $44,732 - $77,883	-19,970 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$3.58 - $4.9 $3,222 - $4,410	-900 Reduced 4.31%	19,970 $78,000
Q2 2018 Jul 13, 2018	BUY	$4.43 - $5.14 $92,454 - $107,271	20,870 New	20,870 $99,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.